Drugs & Therapy Perspectives | 2001(17) articles
- Sertraline: the first SSRI to be approved for the specific treatment of post-traumatic stress disorder
- The next wave of anticonvulsants: are they more efficacious?
- Sepsis and septic shock: early recognition and multipronged approach to management paramount in children
- TDM may be useful for some atypical antipsychotics
- First reports of adverse drug reactions (ADRs) in recent weeks
- New in the marketplace